Articles by Hellen Berger - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Hellen Berger

Report from Brazil

Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.
May 1, 2013

Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.

Report from Brazil

Brazil's major vaccine producer innovates with stem-cell research.
Mar 1, 2013

Brazil's major vaccine producer innovates with stem-cell research.

Report from Brazil

Brazil to locally produce HIV/AIDS antiretroviral drug atazanavir.
Jan 1, 2013

Brazil to locally produce HIV/AIDS antiretroviral drug atazanavir.

Report from Brazil

Brazil's regulatory health authority, Anvisa, plans to establish quality requirements for locally produced pharmaceutical excipients, Anvisa told BioPharm International.
Sep 1, 2012

Brazil's regulatory health authority, Anvisa, plans to establish quality requirements for locally produced pharmaceutical excipients, Anvisa told BioPharm International.

ADVERTISEMENT

ADVERTISEMENT

Click here